Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents

被引：0
|
作者：
Hideaki Miyake
Ryo Sato
Kyohei Watanabe
Yuto Matsushita
Hiromitsu Watanabe
Daisuke Motoyama
Toshiki Ito
Takayuki Sugiyama
Atsushi Otsuka
机构：
[1] Hamamatsu University School of Medicine,Department of Urology
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Metastatic castration-resistant prostate cancer; Cabazitaxel; Third-line treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1745 / 1751
页数：6
相关论文
共 50 条
  • [31] Activity of cabazitaxel in patients with metastatic castration-resistant prostate cancer after treatment with single or dual regimens of novel androgen receptor-targeting agents
    Yukari Bando
    Nobuyuki Hinata
    Tomoaki Terakawa
    Junya Furukawa
    Ken-ichi Harada
    Yuzo Nakano
    Masato Fujisawa
    Medical Oncology, 2017, 34
  • [32] Activity of cabazitaxel in patients with metastatic castration-resistant prostate cancer after treatment with single or dual regimens of novel androgen receptor-targeting agents
    Bando, Yukari
    Hinata, Nobuyuki
    Terakawa, Tomoaki
    Furukawa, Junya
    Harada, Ken-ichi
    Nakano, Yuzo
    Fujisawa, Masato
    MEDICAL ONCOLOGY, 2017, 34 (09)
  • [33] The Relationship between Sarcopenia and Survival after Cabazitaxel Treatment for Castration-Resistant Prostate Cancer
    Onishi K.
    Tanaka N.
    Hori S.
    Nakai Y.
    Miyake M.
    Anai S.
    Fujimoto K.
    Tribologie und Schmierungstechnik, 2022, 69 (04): : 217 - 225
  • [34] Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
    Masahiro Nozawa
    Hirofumi Mukai
    Shunji Takahashi
    Hiroji Uemura
    Takeo Kosaka
    Yusuke Onozawa
    Jun Miyazaki
    Kazuhiro Suzuki
    Koji Okihara
    Yoichi Arai
    Tomomi Kamba
    Masashi Kato
    Yasutomo Nakai
    Hiroshi Furuse
    Haruki Kume
    Hisamitsu Ide
    Hiroshi Kitamura
    Akira Yokomizo
    Takahiro Kimura
    Yoshihiko Tomita
    Keiji Ohno
    Yoshiyuki Kakehi
    International Journal of Clinical Oncology, 2015, 20 : 1026 - 1034
  • [35] Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer: Results of a Compassionate Use Program in The Netherlands
    Wissing, Michel D.
    van Oort, Inge M.
    Gerritsen, Winald R.
    van den Eertwegh, Alfons J. M.
    Coenen, Jules L. L. M.
    Bergman, Andries M.
    Gelderblom, Hans
    CLINICAL GENITOURINARY CANCER, 2013, 11 (03) : 238 - +
  • [36] The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
    Buonerba, Carlo
    Sonpavde, Guru
    Vitrone, Francesca
    Bosso, Davide
    Puglia, Livio
    Izzo, Michela
    Iaccarino, Simona
    Scafuri, Luca
    Muratore, Margherita
    Foschini, Francesca
    Mucci, Brigitta
    Tortora, Vincenzo
    Pagliuca, Martina
    Ribera, Dario
    Riccio, Vittorio
    Morra, Rocco
    Mosca, Mirta
    Cesarano, Nicola
    Di Costanzo, Ileana
    De Placido, Sabino
    Di Lorenzo, Giuseppe
    JOURNAL OF CANCER, 2017, 8 (14): : 2663 - 2668
  • [37] Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
    Nozawa, Masahiro
    Mukai, Hirofumi
    Takahashi, Shunji
    Uemura, Hiroji
    Kosaka, Takeo
    Onozawa, Yusuke
    Miyazaki, Jun
    Suzuki, Kazuhiro
    Okihara, Koji
    Arai, Yoichi
    Kamba, Tomomi
    Kato, Masashi
    Nakai, Yasutomo
    Furuse, Hiroshi
    Kume, Haruki
    Ide, Hisamitsu
    Kitamura, Hiroshi
    Yokomizo, Akira
    Kimura, Takahiro
    Tomita, Yoshihiko
    Ohno, Keiji
    Kakehi, Yoshiyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (05) : 1026 - 1034
  • [38] Safety and efficacy of cabazitaxel in Japanese patients with castration-resistant prostate cancer
    Yamamoto, Teppei
    Ishizuka, Osamu
    Oike, Hiroshi
    Shiozaki, Masashi
    Haba, Tomomi
    Oguchi, Tomohiko
    Iijima, Kazuyoshi
    Kato, Haruaki
    PROSTATE INTERNATIONAL, 2020, 8 (01) : 27 - 33
  • [39] Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxel
    Kosaka, Takeo
    Hongo, Hiroshi
    Mizuno, Ryuichi
    Oya, Mototsugu
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (06) : 683 - 688
  • [40] Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Rii, Junryo
    Yamamoto, Satoshi
    Kamada, Shuhei
    Imamura, Yusuke
    Nakamura, Kazuyoshi
    Komiya, Akira
    Nakatsu, Hiroomi
    Ichikawa, Tomohiko
    PROSTATE, 2020, 80 (07) : 559 - 569
12345